Thomas Vedvick, PhD
Director, Process Sciences
Tom Vedvick joined IDRI in June of 2006. Dr. Vedvick’s research interests are in the development of large scale protein purification and the characterization of proteins for vaccine development. In addition Tom directs the exciting adjuvant formulation program at IDRI. He has more than 70 original articles, and holds 28 issued U.S. patents for diagnostics, vaccines, and therapeutics of infectious diseases and cancer. Tom Vedvick was born and raised in the Pacific Northwest. He obtained a BSc in Chemistry from the University of Puget Sound, a MSc in Chemistry from Western Washington State University and his PhD in Biochemistry from Oregon Health Sciences University. Dr. Vedvick’s postgraduate studies were performed at the School of Medicine, University of California, San Diego. During his postgraduate period his scientific interests were focused on hemoglobinopathies. Dr. Vedvick then worked at the Salk Institute Biotechnology Industrial Associates where he led the protein purification and characterization laboratory. While at SIBIA he collaborated on the development of the Pichia pastoris recombinant protein expression system. Tom left SIBIA to work at Telios Pharmaceuticals where he developed peptide based products for wound healing. Tom then joined Corixa Corporation where he established a protein microsequencing facility and directed the process development group which focused on vaccines for infectious diseases and cancer. Afterwards, Dr. Vedvick spent two years working at LigoCyte pharmaceuticals where he was Director of Process development and project leader in the Norovirus vaccine program. He led the development of purification methods, formulation and cGMP contract manufacturing of the Norovirus,Virus Like Particles. This successful program was the first product that reached a phase I clinical trial for LigoCyte Pharmaceutical. Recent Publications |
- Steven G. Reed, PhD - Head of Research & Development, IDRI Founder
- Curtis D. Malloy, JD, MPH - President
- Karen Kinch - Vice President, Administration
- Anna Marie Beckmann, PhD - Vice President, Development & Regulatory
- Rhea N. Coler, PhD - Vice President, Preclinical Biology
- Sharon Busby, PhD - Director, Project Management
- Darrick Carter, PhD - Director, Formulations
- Joshua Oluoch Odingo, PhD - Director, Chemistry
- Tanya Parish, PhD - Director, Drug Discovery
- Thomas Vedvick, PhD - Director, Process Sciences
- Franco M. Piazza, MD, MPH - Medical Director
- Edward A. Kesicki, PhD - Director, Small-Molecule Drug Discovery